{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:56:57Z","timestamp":1793221017760,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>B-Raf Proto-Oncogene (<jats:italic toggle=\"yes\">BRAF<\/jats:italic>) fusions are rare in melanomas. We present a case of cutaneous melanoma with a Ring Finger Protein 11 (<jats:italic toggle=\"yes\">RNF11<\/jats:italic>)<jats:italic toggle=\"yes\">::BRAF<\/jats:italic> fusion in a 63-year-old man with a history of stage IB melanoma on the right upper back (pT2apN0cM0; nonulcerated with a Breslow thickness of 1.2 mm). Despite initial treatment, the melanoma progressed to multiple metastases. Histopathologically, the tumor cells exhibited epithelioid and rhabdoid morphologies, with occasional giant pleomorphic cells and multinucleation, and were positive for antimelanocytic cocktail (HMB45, Melan-A, tyrosinase) and S100. Next-generation sequencing of a metastatic specimen identified an <jats:italic toggle=\"yes\">RNF11::BRAF<\/jats:italic> fusion and <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter mutation, but no other somatic mutations (eg, <jats:italic toggle=\"yes\">BRAF<\/jats:italic>, <jats:italic toggle=\"yes\">NRAS<\/jats:italic>, <jats:italic toggle=\"yes\">KIT<\/jats:italic>) or copy number variations were detected. The patient died to melanoma approximately 58 months after initial diagnosis, despite several lines of systemic therapy, including immunotherapies and a mitogen-activated protein kinases 1 and 2 inhibitor. <jats:italic toggle=\"yes\">RNF11::BRAF<\/jats:italic> fusions are known oncogenic drivers in histiocytic disorders such as Erdheim\u2013Chester disease and non-Langerhans cell histiocytosis. Although <jats:italic toggle=\"yes\">BRAF<\/jats:italic> fusions are commonly observed in Spitz melanocytic neoplasms, the discovery of the <jats:italic toggle=\"yes\">RNF11::BRAF<\/jats:italic> fusion in melanomas is unprecedented. Our case represents a triple wild-type, clinically aggressive melanoma of possibly non-Spitz lineage with an ultraviolet signature and a rare <jats:italic toggle=\"yes\">BRAF<\/jats:italic> fusion, contributing to the expanding body of literature on <jats:italic toggle=\"yes\">BRAF<\/jats:italic>-fused melanomas.<\/jats:p>","DOI":"10.1097\/dad.0000000000002936","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T20:00:24Z","timestamp":1741118424000},"page":"391-394","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Melanoma With RNF11::BRAF Fusion: A Novel Fusion Previously Undescribed in Melanoma"],"prefix":"10.1097","volume":"47","author":[{"given":"Yan","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Curry","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Torres-Cabala","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5867-1403","authenticated-orcid":false,"given":"Woo Cheal","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"R1-20250418","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1038\/ncomms4116","article-title":"Kinase fusions are frequent in Spitz tumours and spitzoid melanomas","volume":"5","author":"Wiesner","year":"2014","journal-title":"Nat Commun"},{"key":"R2-20250418","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pathol.2015.12.007","article-title":"Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy","volume":"48","author":"Wiesner","year":"2016","journal-title":"Pathology"},{"key":"R3-20250418","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/DAD.0000000000002778","article-title":"Spitz melanoma with SLC20A1::ALK fusion: a novel fusion previously undescribed in Spitz melanocytic neoplasm","volume":"46","author":"Cho","year":"2024","journal-title":"Am J Dermatopathol"},{"key":"R4-20250418","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/cup.14605","article-title":"Spitz melanocytic neoplasms with MLPH::ALK fusions: report of two cases with previously unreported features and literature review","volume":"51","author":"Salah","year":"2024","journal-title":"J Cutan Pathol"},{"key":"R5-20250418","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.4775","article-title":"NTRK3 kinase fusions in Spitz tumours","volume":"240","author":"Yeh","year":"2016","journal-title":"J Pathol"},{"key":"R6-20250418","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41379-019-0384-8","article-title":"Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations","volume":"33","author":"Houlier","year":"2020","journal-title":"Mod Pathol"},{"key":"R7-20250418","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/s41379-022-01138-z","article-title":"Identification of fusions with potential clinical significance in melanoma","volume":"35","author":"Moran","year":"2022","journal-title":"Mod Pathol"},{"key":"R8-20250418","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41388-018-0514-7","article-title":"BRAF fusions identified in melanomas have variable treatment responses and phenotypes","volume":"38","author":"Turner","year":"2019","journal-title":"Oncogene"},{"key":"R9-20250418","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1158\/1078-0432.CCR-13-1746","article-title":"BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition","volume":"19","author":"Hutchinson","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R10-20250418","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/DAD.0000000000002796","article-title":"BCR::ZNF711 and BCR::CYLC2 fusions: novel BCR fusions expanding the molecular spectrum of gene fusions in melanoma","volume":"46","author":"Ibrahim","year":"2024","journal-title":"Am J Dermatopathol"},{"key":"R11-20250418","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.celrep.2019.09.009","article-title":"Genetic heterogeneity of BRAF fusion kinases in melanoma affects drug responses","volume":"29","author":"Botton","year":"2019","journal-title":"Cell Rep"},{"key":"R12-20250418","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/cup.14263","article-title":"Fatal melanoma with a novel MYO5A-BRAF fusion and small associated conventional nevus: a case report and review of literature","volume":"49","author":"Clark","year":"2022","journal-title":"J Cutan Pathol"},{"key":"R13-20250418","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/biom10111538","article-title":"RNF11 at the crossroads of protein ubiquitination","volume":"10","author":"Mattioni","year":"2020","journal-title":"Biomolecules"},{"key":"R14-20250418","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41408-022-00693-7","article-title":"Clinical and therapeutic implications of BRAF fusions in histiocytic disorders","volume":"12","author":"Zanwar","year":"2022","journal-title":"Blood Cancer J"},{"key":"R15-20250418","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"key":"R16-20250418","doi-asserted-by":"crossref","first-page":"100149","DOI":"10.1016\/j.modpat.2023.100149","article-title":"Spectrum of melanocytic tumors harboring BRAF gene fusions: 58 cases with histomorphologic and genetic correlations","volume":"36","author":"Roy","year":"2023","journal-title":"Mod Pathol"},{"key":"R17-20250418","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.18632\/oncotarget.27788","article-title":"MEK inhibitors in non-V600 BRAF mutations and fusions","volume":"11","author":"Johnson","year":"2020","journal-title":"Oncotarget"},{"key":"R18-20250418","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000002302","article-title":"The clinical, morphologic, and molecular spectrum of BRAF fusion Spitz tumors","volume":"48","author":"Sharma","year":"2024","journal-title":"Am J Surg Pathol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T13:00:30Z","timestamp":1744981230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002936","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}